Home › Chronic Lymphocytic Leukemia › Tennessee › Memphis
Chronic Lymphocytic Leukemia clinical trials in Memphis, TN
3 studies for Chronic Lymphocytic Leukemia are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RecruitingPhase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi away
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi away
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
RecruitingPhase 3
- Baptist Memorial Hospital and Cancer Center-Memphis, Memphis
- Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven · 12 mi away
- Baptist Memorial Hospital and Cancer Center-Collierville, Collierville · 23 mi away
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RecruitingPhase 1/2
- Baptist Clinical Research Institute, Memphis
Chronic Lymphocytic Leukemia trials in other cities
- Boston, MA31 studies
- Columbus, OH29 studies
- Durham, NC28 studies
- Washington, DC22 studies
- Seattle, WA22 studies
- Rochester, MN20 studies
- New York City, NY20 studies
- Houston, TX18 studies
- Baldwin Park, CA18 studies
- Cincinnati, OH15 studies
- Milwaukee, WI15 studies
- Chicago, IL14 studies
Other studies in Memphis
- Cancer (all types)30 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer21 studies
- Sickle Cell Disease19 studies
- Acute Lymphoblastic Leukemia17 studies
- Lung Cancer17 studies
- Acute Myeloid Leukemia14 studies
- Heart Failure12 studies
- Melanoma11 studies
- Soft Tissue Sarcoma10 studies
- Colorectal Cancer10 studies
- Type 2 Diabetes10 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.